Skip to main content
Ophthalmology Science logoLink to Ophthalmology Science
. 2025 Oct 22;6(1):100981. doi: 10.1016/j.xops.2025.100981

Macular Thickness and Its Associated Factors in a Healthy Cynomolgus Colony: The Non-Human Primates Eye Study

Hongyi Liu 1,2, Simeng Hou 1,2, Sirui Zhu 1,2, Weihai Liu 3, Moksada Regmi 3, Chenlong Yang 3, Jian Wu 4,∗,, Ningli Wang 1,2,4,∗,∗∗
PMCID: PMC12768913  PMID: 41502466

Abstract

Purpose

The research aims to investigate the normal macular thickness range in a healthy cynomolgus colony and examine its association with relevant parameters.

Design

Cross-sectional observational study.

Subjects

A total of 418 healthy cynomolgus monkeys (mean age, 13.22 ± 7.86 years; range, 1–29 years) from the Non-Human Primates Eye Study conducted between 2021 and 2022.

Methods

All included monkeys underwent comprehensive ocular measurements, including macular thickness measurement using spectral-domain OCT. To account for the correlation between eyes, generalized linear mixed models were applied. To assess the gender differences in macular thickness and volume, independent T-tests were employed. Linear regression, including quadratic terms (Age2), was used to examine the relationships between macular subregions and age. Additionally, univariate analyses and multivariate linear regression were conducted to evaluate the associations between the central, average inner ring, and average outer macular thickness and various systemic and ophthalmic parameters.

Main Outcome Measures

Macular thickness in ETDRS subfields and its associations with age and ocular parameters.

Results

Sex statistically significant differences were observed only in the superior sector of the inner ring and in the temporal sector of the outer ring after adjustment. In inner rings, all 4 subfields exhibited a significant age-related decline; meanwhile, temporal and superior subfields decreased with increasing age in the outer ring. After adjustment, macular thickness was independently associated with age and end-of-anesthesia intraocular pressure (IOP) in the central region, axial length (AXL) in the average inner ring, AXL and mid-anesthesia IOP in the average outer ring, and AXL and end-of-anesthesia IOP for the overall average thickness.

Conclusions

This study provided valuable reference data on macular thickness in different ages and sexes of cynomolgus which could be utilized in preclinical nonhuman primate experiments.

Financial Disclosure(s)

Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Keywords: Associated factors, Macular thickness, Nonhuman primates


As of 2010, the number of individuals with age-related macular degeneration (AMD) had reached 23 million.1 Meanwhile, AMD is the leading cause of blindness among people >50 years of age in the United States.2 It is therefore important to focus on the prevention and treatment of age-related macular diseases in an aging society. The advent of anti-VEGF agents has advanced the treatment of neovascular AMD, resulting in a reduction in blindness caused by neovascular AMD.3, 4, 5 The treatment development work currently focuses on non-neovascular AMD.6 Therapeutic options are becoming increasingly diverse with advances in research technologies, such as nanotherapeutics, port delivery systems, radiation therapy, gene therapy, and cell therapy.4, 5, 6 The safety and efficacy of these new treatments are evaluated in preclinical animal studies before proceeding to phase I and II trials. As the most common research animal, mice cannot be employed in macular preclinical studies due to the absence of a macula in mice eyes. In contrast, the ocular anatomy of nonhuman primates (NHPs) is extremely similar to that of humans.7,8 Meanwhile, NHPs share 90% of their DNA sequences with humans, reflecting their close evolutionary relationship.9,10 Consequently, NHPs have emerged as the most valuable experimental model for preclinical ocular research, providing valuable insights into both anatomical and genetic aspects of eye-related studies.

Evidence has demonstrated that the alterations of macular thickness are closely correlated with various eye disorders, optic neuropathy, diabetic retinopathy, and retinal vein occlusion, besides AMD.11,12 Exploring the normal range of macular thickness plays an important role in monitoring and diagnosing a wide range of retinal diseases. Recognized as one of the parameters in the evaluation of many retinal disorders, the normal range of macular thickness plays a significant role in clinical assessment. Meanwhile, relevant human macular parameters do not provide an equivalent reference for preclinical investigations in NHPs because of species differences.

Current studies involving NHPs have generally relatively small sample sizes and limited age spans, which may not provide sufficiently robust evidence to accurately reflect actual conditions. Therefore, establishing the reference value of NHP macular thickness is essential to serve as a standard.

Spectral or Fourier domain OCT, known for its quantitative capability and higher sensitivity,13 can measure subtle changes in macular thickness compared with traditional methods such as fluorescein angiography and time-domain OCT.14, 15, 16 Thus, spectral-domain OCT has been widely applied in clinical trials and scientific research,17, 18, 19, 20 and it is the most commonly used equipment in scientific studies of NHPs.21,22

This study involved 418 healthy monkeys, ranging in age from 1 to 29 years. The purpose was to analyze the normal range and associated parameters of normal macular thickness in cynomolgus monkeys, aiming to provide a reference for preclinical macular research of NHPs.

Methods

Animals and Ethnic Statement

Nonhuman primates (Macaca fascicularis, cynomolgus) involved in this study were from Huazhen Bioscience, located in Guangzhou, which specializes in breeding monkeys for use as animal models in preclinical studies of biopharmaceuticals. All NHPs in this study grew naturally without any invasive or biomedical interventions, including drug treatment, adeno-associated virus intervention, or surgical intervention related to preclinical experiments. Receiving regular 12-h sunlight to maintain a normal circadian rhythm, macacas were housed in a dedicated feeding facility maintained at approximately 16 °C to 26 °C temperature and approximately 40% to 70% room humidity. Fresh water, fruits, and primate chow (12% of calories from fat, 18% from protein, and 70% from carbohydrates, 200–300 g/d) were provided ad libitum to cynomolgus monkeys to meet their nutritional needs. Music and toys were supplied for entertainment. Furthermore, their physical condition was continuously monitored by skilled veterinarians.

The Huazhen Bioscience has been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care to perform animal scientific research in China. All procedures in this study complied with the Association for Research in Vision and Ophthalmology’s Statement for the Use of Animals in Ophthalmic and Vision Research and adhered to the Declaration of Helsinki. The study was approved by the Ethical Committee of the Guangzhou Huazhen Biosciences Company (Ethics Number: 2020-168).

Standardized Examination Process

Detailed examination procedures have been described in our published paper.10 All included monkeys underwent the standardized systemic and comprehensive ocular examination. After administration of an appropriate dose of anesthetic, the animals were fixed in the proper position. Body weight and intraocular pressure (IOP) were recorded; meanwhile, slit lamp examination, fundus photography, A-scan ultrasonography examination, anterior segment OCT, and spectral-domain OCT images were performed. Throughout the entire examination, respiration and heart rate were monitored at all times.

Ocular Examination

After being intramuscularly (IM) anesthetized with compound mixed tiletamine (4 mg/kg body weight, Virbac) and ketamine (0.2 mg/kg body weight, Sumianxin, Shengda Animal Medicine), the monkeys were stabilized in a supine position on a soft flat work desk by a skilled technician. The Icare tonometer (TA01i, Icare) was used to measure IOP. By holding the Icare tonometer to the monkey's pupil and keeping the monkey's head in gaze, 6 measurements were automatically obtained. To ensure data availability, this procedure was repeated 3 times, and the mean IOP was calculated. The IOP of all subjects was measured at the beginning, middle, and end of anesthesia. The anterior segment structure of cynomolgus monkeys was carefully examined by an experienced ophthalmologist using silt lamp biomicroscopy (TOPCON Slit-lamp SL-D701), such as the eyelids, anterior chamber, and cornea. A-scan ultrasonography (TOMEY AL–4000) was used to measure lens thickness, AXL, and anterior chamber depth. Autorefraction and corneal radius of curvature were tested by the Fario FXR–710 (Fario), and spherical equivalent was calculated automatically by this autorefractor. The anterior-segment OCT (Heidelberg Engineering GmbH) was used to measure the anterior chamber and its angle.

Macular Thickness Measurement by Spectral-Domain OCT

The monkeys were anesthetized, and the 0.5% tropicamide phenylephrine hydrochloride eye drop was utilized for pupil dilation. An experienced operator used the machine (SPECTRALIS HRA + OCT, Heidelberg Engineering GmbH) to focus on the pupil first and readjust the camera to focus on the macular fovea, then chose the “volume scan” and acquired images with 49 line B-scan and 20 automated real-time tracking frames. The built-in software automatically generated the macular thickness maps. After completing the OCT measurement, the relevant machine parameters have been set. After finding the thickness map tab in the menu bar, the 1-, 3-, and 6-mm ETDRS has been chosen to get the data. The map consisted of 3 concentric circles and was divided into 9 sectors (the central macular areas, the inner ring, and the outer ring) following the definition of the ETDRS. Both the inner and outer rings were further subdivided into the nasal, temporal, superior, and inferior quadrants. Furthermore, we used the software's divider for automatic image segmentation, and manually corrected the automatic segmentation when a problem occurred. The “Thickness Map Single Exam Report” provided thickness information. Images with inadequate quality or with a signal strength index of <15 decibels (as recommended by the manufacturer) were excluded from analysis.

Inclusion and Exclusion

In this study, none of the cynomolgus monkeys received any biomedical interventions, and all included female monkeys were not pregnant, avoiding the drug effects and the effects of anesthetics on the fetus. The OCT images were carefully reviewed to exclude images with poor quality, such as images with indistinct features or artifacts. After data and OCT image quality control, as well as review of the fundus photographs, 34 eyes were excluded due to the ocular diseases affecting macular thickness, including retinal vein occlusion and hypertensive retinopathy. Additionally, 3 individuals with suspected spontaneous glaucoma and 50 individuals with high myopia (spherical equivalent < –5.00 diopters) were excluded. The definition of glaucoma was according to the recommendations of the Association of International Glaucoma Societies.23 Ultimately, 836 eyes were included for data analysis (Fig 1).

Figure 1.

Figure 1

Flow diagram showing the inclusion criteria for cynomolgus monkeys and the reasons for exclusion.

Statistical Analysis

Data from each normal eye were included in the analysis. All statistical analyses were performed using the Statistical Package for the Social Sciences version 25.0 (SPSS Inc). Normally distributed data were shown by mean and standard deviation. Average macular thickness across regions and quadrants was compared between females and males using T-tests. To account for correlation between both eyes, potential confounding factors, including age, body weight, and AXL, generalized linear mixed models (GLMMs) were subsequently performed following the t-tests. Quadratic terms of age were included in linear regression analyses to explore the relationship between age and thickness in each macular subregion. Univariate analysis and multiple linear regression analyses, as well as GLMM, were utilized to assess the correlation between the macular thickness and relevant factors.

Results

A total of 418 monkeys were included in this analysis (253 female and 165 male). Table 1 provides a detailed comparison of basic demographic data and ocular parameters of the 2 groups in the included and excluded subjects. The mean age and weight of included monkeys were 13.22 ± 7.86 years old and 4.20 ± 1.33 kg, respectively. No significant statistical differences were observed between the 2 groups in terms of body weight or sex distribution. Compared with the excluded group, the included group was younger and had lower IOP, shorter AXL (P < 0.001), spherical equivalent (P < 0.001), anterior chamber depth (P < 0.001), and thinner central corneal thickness (P = 0.011).

Table 1.

Comparisons of Baseline Characteristics between the Included and Excluded Groups

Parameters Included Group Excluded Group t/x2 P Value
Total, N 418 70
Age (yrs) 13.22 ± 7.86 17.49 ± 5.42 –5.65 <0.001
Weight (kg) 4.20 ± 1.33 4.54 ± 1.64 –1.75 0.081
Gender (female %) 253 (60.52) 165 (39.47) 1.63 0.202
IOP (mmHg)
 At the beginning of anesthesia 23.41 ± 3.46 25.08 ± 3.74 –5.10 <0.001
 In the middle of anesthesia 20.15 ± 5.02 21.43 ± 4.65 –2.75 0.006
 At the end of anesthesia 18.02 ± 3.98 19.45 ± 4.49 –3.46 0.001
 CCT 453.69 ± 38.15 465.45 ± 51.38 –2.56 0.011
 AXL (mm) 18.11 ± 0.86 19.42 ± 1.14 –12.89 <0.001
 SE (D) –0.45 ± 1.90 –6.21 ± 4.94 13.57 <0.001
 ACD (mm) 3.03 ± 0.39 3.22 ± 0.33 –6.78 <0.001

ACD = anterior chamber depth; AXL = axial length; CCT = central corneal thickness; D = diopters; IOP = intraocular pressure; SE = spherical equivalent.

Values for mean ± standard deviation or total number (percentage) are shown. Statistically significant P values (P < 0.05) are in boldface.

Table 2 presents the gender differences in macular thickness and volume in the selected healthy cynomolgus colony. The average macular thickness of the cohort was 333.91 ± 28.01 μm, with the average values of 343.04 ± 25.72 μm for the inner ring and 343.12 ± 27.08 μm for the outer ring. In both males and females, the central macular region was thinnest, measuring 322.24 ± 39.17 μm and 323.91 ± 44.27 μm, respectively. In addition, within both the inner and outer rings, the temporal subfield was the thinnest, and the nasal subfield was the thickest. The distribution of macular thickness by sex is shown in Figure 2. Statistically significant differences were observed only in the superior sector of the inner ring (adjusted P values = 0.006) and in the temporal sector of the outer ring (adjusted P values = 0.012) after using GLMM.

Table 2.

The Difference in Macular Thickness and Volume by Gender

Macular Thickness (μm) Female Male P Value Adjusted P Value G
N 253 165
Central macula 323.91 ± 44.27 322.24 ± 39.17 0.588 0.509 323.18 ± 42.30
Inner ring
 Temporal 321.38 ± 35.22 335.03 ± 27.47 <0.001 0.145 326.66 ± 33.09
 Superior 343.43 ± 31.42 352.54 ± 27.02 <0.001 0.006 346.96 ± 30.10
 Nasal 348.40 ± 32.59 357.51 ± 25.75 <0.001 0.078 352.70 ± 27.78
 Inferior 335.40 ± 34.84 345.47 ± 31.57 <0.001 0.231 339.29 ± 33.94
 Average inner ring 336.98 ± 27.46 347.63 ± 21.28 <0.001 0.912 343.04 ± 25.72
Outer rings
 Temporal 327.66 ± 28.16 339.20 ± 23.41 <0.001 0.012 332.13 ± 26.99
 Superior 345.84 ± 40.42 349.47 ± 27.71 0.168 0.968 347.24 ± 36.07
 Nasal 349.89 ± 29.68 357.12 ± 23.88 <0.001 0.403 353.93 ± 28.98
 Inferior 342.96 ± 30.92 348.11 ± 37.32 0.035 0.214 344.95 ± 33.62
 Average outer ring 340.34 ± 28.99 347.53 ± 23.09 <0.001 0.899 343.12 ± 27.08
 Average macular thickness 321.71 ± 65.44 318.00 ± 80.37 0.466 0.893 333.91 ± 28.01
 Macular volume 3.23 ± 0.56 3.25 ± 0.25 0 0.482 0.319 3.23 ± 0. 47

G: the average values for the female and male. Statistically significant P values (P < 0.05) are shown in bold. P value represents the result of the unadjusted t-test. Adjusted P values were derived from generalized linear mixed models after controlling for intereye correlation, age, body weight, and axial length.

Figure 2.

Figure 2

The distribution of macular thickness by gender. RPE = retinal pigment epithelium.

Table 3 presents the distribution of macular thickness (including 9 subfields) and volume measurements by age, ranging from 1 to 29. The subjects were categorized into 4 age groups: juvenile (1–4 years), subadult (4–9 years), adult (9–20 years), and geriatric (20∼29 years).24 Significant age-related variations were observed in most quadrants, showing a trend with increasing age. Central macular thickness increased from the juvenile group (309.75 ± 37.69 μm) and the subadult group (307.83 ± 39.80 μm) to the adult group (336.55 ± 45.28 μm), and then decreased in the geriatric group (326.36 ± 34.83 μm). Quadratic regression confirmed a significant inverted U-shaped relationship (Age2 B = –0.18, 95% confidence interval –0.29 to –0.09; P = 0.001). In inner rings, all 4 subfields exhibited a significant age-related decline (P < 0.05); meanwhile, temporal and superior subfields decreased with increasing age in the outer ring (Fig S1, available at www.ophthalmologyscience.org). Furthermore, compared with Table 2, the nasal subfield remained the thickest and the temporal subfield the thinnest quadrant in both inner and outer rings.

Table 3.

Macular Thickness and Volume Measurements by OCT in NHPs by Age Group

Macular Thickness (μm)
Age Group (yr)
Trend for Age
1∼4 Juvenile 4–9
Subadult
9–20
Adult
20∼29
Geriatric
Age/Age2
B (95% CI)
Age/Age2
P Value
No. of subjects 84 87 160 87
Central macula∗ 309.75 ± 37.69 307.83 ± 39.8 336.55 ± 45.28 326.36 ± 34.83 –0.18 (–0.29,–0.09) 0.001
Inner rings
 Temporal 342.21 ± 24.63 330.88 ± 31.94 321.53 ± 36.82 316.51 ± 27.83 –1.17 (–1.45,–0.89) <0.001
 Superior 354.69 ± 26.94 349.83 ± 26.44 343.82 ± 33.03 342.22 ± 29.20 –0.63 (–0.89,–0.37) <0.001
 Nasal 361.96 ± 27.15 354.51 ± 24.96 349.01 ± 35.67 344.96 ± 25.33 –0.78 (–1.04,–0.51) <0.001
 Inferior 349.95 ± 28.58 337.80 ± 36.39 338.62 ± 35.29 330.97 ± 32.26 –0.63 (–0.93,–0.34) <0.001
Outer rings
 Temporal 342.11 ± 23.91 340.70 ± 22.59 324.88 ± 29.51 326.48 ± 23.77 –1.04 (–1.27,–0.82) <0.001
 Superior 352.55 ± 31.53 355.30 ± 22.64 345.63 ± 45.74 337.05 ± 27.49 –0.18 (–1.13,–0.51) <0.001
 Nasal∗ 357.69 ± 23.06 360.16 ± 23.17 349.96 ± 31.82 345.42 ± 25.76 –0.04 (–0.09,–0.01) 0.152
 Inferior∗ 340.79 ± 36.03 354.67 ± 40.58 343.69 ± 30.73 342.40 ± 33.06 –0.08 (–0.14,–0.06) 0.160
 Volume (mm3) 3.25 ± 0.16 3.23 ± 0.17 3.18 ± 0.32 3.15 ± 0.32 –0.002 (–0.006,0.002) 0.282

CI = confidence interval; NHPs = nonhuman primates.

Parameters marked with ∗indicate that a quadratic term (Age2) was included in the regression model to assess for nonlinear associations. Statistically significant P values (P < 0.05) are in boldface.

Building on the age group analysis, we further explored the associations between demographic and ocular parameters and macular thickness. Univariate analyses were first conducted to preliminarily assess the relationships (Table S1, available at www.ophthalmologyscience.org).

Parameters that showed statistical significance were then included in multiple linear regression and GLMM analyses. The results are shown in Tables 4 and 5. For central macular thickness, age (P < 0.001) and IOP at the end of anesthesia (P = 0.001) remained significant predictors after adjustment. In the inner ring, AXL (P = 0.002) was independently correlated with thickness, while IOP in the middle of anesthesia (P = 0.438) lost statistical significance after adjustment using the GLMM model. For the outer ring, AXL (P < 0.001) and IOP measured in the middle of anesthesia (P = 0.025) were independently associated with average thickness after GLMM adjustment. Overall average macular thickness was independently associated with AXL (P < 0.001) and IOP measured at the end of anesthesia (P = 0.048).

Table 4.

Multiple Linear Regression Analysis of Ocular Factors Associated with Macular Thickness

Macular Regions Parameters β (B) 95% CI P Value
Central macula Age 1.02 0.63–1.41 <0.001
IOP at the end of anesthesia 1.37 0.59–2.16 0.001
Average inner ring AXL –23.17 –29.50 to 16.84 0.002
IOP in the middle of anesthesia 1.28 0.34–2.22 0.007
Average outer ring Age (years) –0.90 –1.58 to –0.22 0.010
IOP in the middle of anesthesia 0.87 0.13–1.61 0.020
AXL –13.22 –18.40 to –8.05 <0.001
ACD 13.71 2.23–25.19 0.019
Overall average macula IOP in the middle of anesthesia 0.85 0.02–1.69 0.045
IOP in the end of anesthesia 1.11 0.08–2.15 0.034
AXL –10.95 –14.91 to –6.98 <0.001

ACD = anterior chamber depth; AXL = axial length; CI = confidence interval; IOP = intraocular pressure.

Statistically significant P values (P < 0.05) are in boldface.

Table 5.

Generalized Linear Mixed Model Analysis of Ocular Factors Associated with Macular Thickness

Macular Regions Parameters β (B) 95% CI P Value
Central macula Age 1.03 0.57–1.49 <0.001
IOP at the end of anesthesia 1.26 0.37–2.15 0.005
Average inner ring AXL –3.63 –6.24 to –1.02 0.006
IOP in the middle of anesthesia –0.17 –0.60 to 0.26 0.438
Average outer ring Age (years) –0.15 –1.07 to 0.75 0.734
IOP in the middle of anesthesia 1.12 0.14–2.10 0.025
AXL –16.62 –23.32 to –9.92 <0.001
ACD 2.78 –12.20 to 17.76 0.715
Overall average macula IOP in the middle of anesthesia 0.87 –0.02 to 1.78 0.056
IOP in the end of anesthesia 1.12 0.008–2.24 0.048
AXL –11.30 –15.61 to –6.98 <0.001

ACD = anterior chamber depth; AXL = axial length; CI = confidence interval; IOP = intraocular pressure.

Statistically significant P values (P < 0.05) are in boldface.

Discussion

A total of 418 cynomolgus monkeys of different ages were included from a healthy breeding colony at Huazhen, South China. This study revealed the normal range of monkey macular thickness across different sexes, regions, and age groups, and further examined the associations between macular thickness and various ocular and systemic factors.

In our study, the average macular thickness was 333.91 ± 28.01 μm. Compared with the research published in 2019,25 the normal range of macular thickness in the temporal inner (327 ± 17 vs. 326.66 ± 33.09 μm) and inferior inner quadrants (339 ± 17 vs. 339.29 ± 33.94 μm) was similar. But in other quadrants, the differences were notable, the macular thickness comparison in other subfields were 341 ± 14 versus 346.96 ± 30.10 μm (superior inner), 341 ± 18 versus 352.70 ± 27.78 μm (nasal inner), 299 ± 20 versus 332.13 ± 26.99 (temporal outer), 320 ± 16 versus 347.24 ± 36.07 μm (superior outer), 332 ± 23 versus 344.95 ± 33.627 μm (inferior outer), and 337 ± 18 μm versus 353.93 ± 28.98 μm (nasal outer). Summing up the results, we found that the thickness of most macular regions was significantly thicker compared to the study performed in 2019, though all the monkeys were cynomolgus monkeys. There are several reasons that might cause these differences.25 First, in the study by Denk et al,25 the subjects age ranged from 20 months to 50 months, which is nearly equivalent to the minimum age of subjects in our study. Several pediatric epidemiological studies showed that the macular thickness would become thicker with aging, which may also happen to young monkeys.26, 27, 28 Second, as a large sample epidemiological study, our research included a wide age range of subjects. Third, the monkeys in the study by Denk et al25 had a Mauritian genetic background. Previous studies have shown that Mauritian cynomolgus macaques, due to a founder effect and long-term island isolation, exhibit markedly reduced genetic diversity and clear differences from mainland Asian populations.29,30 Therefore, genetic background may also contribute to differences in macular thickness. Supporting this, human studies have reported that macular thickness can vary across ethnic groups.31, 32, 33 However, whether genetic differences between cynomolgus monkey populations indeed influence macular thickness remains to be further investigated and verified.

Compared with the epidemiological research for human macular thickness (Table 6), we found that the thickness of all 9 regions was greater in NHPs than in humans. Moreover, the study shows that the macular volume was approximately 2 times thinner in monkeys than in humans, which might be attributed to the smaller somatotype of monkeys.34 What’s more, the temporal region was thinnest and the nasal region was greatest in the inner ring, whether in monkeys or humans. But in outer rings, our region trends in compliance with some studies35,36 and in contrast to some studies,37 which suggests that there is still controversy. For gender difference, males showed significantly greater thickness than females in the superior subfield of the inner ring and in the temporal subfield of the outer ring (P = 0.006 and P = 0.012, respectively). The central subfield thickness was slightly greater in females than in males (P = 0.509), consistent with the findings of Denk et al25 in cynomolgus monkeys. However, the central subfield thickness of males was usually thicker than females in humans.38,39 Although the gender difference in central subfield thickness was not statistically significant in our study, whether the thickness of the macula center in monkeys is different from that in humans needs to be further explored. Furthermore, in our study, the outer rings appeared thicker than the inner rings, which was the opposite of what was observed in humans.40,41 Given the large sample size and the wide age span of the monkeys, this may result in the relatively large variation influenced by age and the variation directly reflected in the standard deviation of the value. Finally, similar to humans, macular thickness decreases with age in some quadrants. Overall, there is a high degree of similarity between human and monkey macular thickness, although some differences exist. Importantly, these cross-species comparisons are descriptive and should be interpreted with caution, as there is currently no established age translation between monkeys and humans.

Table 6.

Macular Thickness and Volume in Previous Nonhuman Primate and Human Eye Studies

Study Year N Monkey/Human Age (Year/Month) OCT Macular Volume Central Macula Inner
Outer
Inferior Nasal Superior Temporal Inferior Nasal Superior Temporal
Current study 2023 418 Cynomolgus monkey 4∼29 Heidelberg Engineering 3.23 ± 0. 47 323.18 ± 42.30 339.29 ± 33.94 352.70 ± 27.78 346.96 ± 30.10 326.66 ± 33.09 344.95 ± 33.62 353.93 ± 28.98 347.24 ± 36.07 332.13 ± 26.99
Denk et al25 2019 160 Cynomolgus monkey 20th∼50th Heidelberg Engineering 244 ± 21 339 ± 17 341 ± 18 341 ± 14 327 ± 17 332 ± 23 337 ± 18 320 ± 16 299 ± 20
Patel et al35 2015 67 321 Human 40∼69 Topcon 3D OCT1000 Mark II 7.87 ± 0.37 264.5 ± 22.9 311.9 ± 16.2 319.5 ± 16.3 315.3 ± 16.1 304.0 ± 15.5 263.0 ± 15.0 287.2 ± 15.8 269.7 ± 14.3 255.6 ± 14.3
Duan42 2010 2230 Human 30∼70+ Stratus OCT, Model 3000 6.761 ± 0.516 260.0 ± 15.5 252.9 ± 19.1 261.6 ± 16.2 246.7 ± 16.7 225.5 ± 13.3 258.514.5 240.0 ± 13.5 227.0 ± 13.1
Myers et al43 2015 4926 Human 43∼86 Topcon 3D-OCT 1000-Mark II 332.9 ± 17.2 341.3 ± 17.9 334.9 ± 15.9 329.0 ± 17.3 281.3 ± 14.7 306.0 ± 17.0 288.3 ± 13.8 283.2 ± 15.1
Gupta et al36 2013 490 Human 40∼80 Cirrus HD-OCT 10.09 (0.41) 250.38 (20.58) 319.09 (14.55) 325.14 (15.77) 323.11 (15.10) 310.00 (14.45) 266.19 (12.66) 299.38 (14.17) 279.62 (13.06) 261.48 (12.21)
Natung et al44 2016 500 Human >18 Model 500; Carl Zeiss Meditec 313.47 ± 19.14 316.98 ± 19.16 317.16 ± 17.84 303.38 ± 16.24 266.68 ± 22.15 294.46 ± 17.37 277.59 ± 17.83 260.70 ± 14.63
Al-Zamil et al45 2017 158 Human 18–56 Cirrus HD-OCT 8.48 ± 0.35 240.40 ± 18.26 315.94 ± 21.05 320.23 ± 20.71 318.38 ± 21.69 303.81 ± 20.70 265.75 ± 17.31 293.18 ± 21.21 276.37 ± 16.58 259.56 ± 25.24

This research involved 418 monkeys and 836 eyes, which is the largest study about normal NHP macular thickness to date. Moreover, the age distribution of the participants ranged from 1 to 29 years old, providing a comprehensive view of macular thickness in different age groups. These findings offer valuable guidance for selecting monkeys of the appropriate age for various purposes or preclinical experiments. What’s more, because of the high price of NHPs, macula-related studies often include only 1 or 2 animals in the control group, making it difficult to determine whether the macula thickness of the selected monkey is within the normal range. Providing the normal range of macular thickness, our study may help to partially address this problem. However, there are still limitations in our study. First, female monkeys accounted for 60.5% of all subjects. In a concentrated life environment, the natural territorial awareness will make some male monkeys die from fighting. In addition, many biopharmaceutical companies preferentially select young male monkeys for biological experiments. Second, this study is limited by the lack of test–retest validation for macular thickness measurements. Although all operators were trained according to standardized protocols, the absence of repeated measurements may limit the assessment of measurement variability. Third, all measurements were performed under general anesthesia, which may slightly affect IOP and macular thickness. Additionally, all monkeys were from a single breeding colony, which may limit the generalizability of the findings.

In conclusion, our study measured the distribution of macular thickness in a healthy cynomolgus colony and found that the macular thickness of monkeys was thicker than humans. In addition, our findings provided normative reference values for preclinical NHP studies about macular diseases.

Acknowledgments

The authors wish to thank the Non-human Primate Eye Study Group, the Guangzhou Huazhen Biosciences Company, and all the staff in Huazhen Laboratory Animal Breeding Centre for their valuable contributions to this study.

Manuscript no. XOPS-D-25-00469.

Footnotes

Supplemental material available at www.ophthalmologyscience.org.

Disclosures:

All authors have completed and submitted the ICMJE disclosures form.

The authors made the following disclosures:

This work was supported by the National Natural Science Foundation of China (82130029).

HUMAN SUBJECTS: No human subjects were included in this study.

ANIMAL SUBJECTS: Animal subjects were used in this study. The HZ-Bio has been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) to perform animal scientific research in China. All procedures in this study complied with the Association for Research in Vision and Ophthalmology’s Statement for the Use of Animals in Ophthalmic and Vision Research and adhered to the Declaration of Helsinki. The study was approved by the Ethical Committee of the Guangzhou Huazhen Biosciences Company (Ethics Number: 2020–168).

Author Contributions:

Conception and design: H. Liu, Wu

Analysis and interpretation: H. Liu

Data collection: Hou, Zhu, W. Liu, Regmi, Yang, Wu

Obtained funding: Wang

Overall responsibility: H. Liu, Wang

Contributor Information

Jian Wu, Email: karena.wu@foxmail.com.

Ningli Wang, Email: wningli@vip.163.com.

Supplementary Data

Figure S1
mmc1.pdf (1.2MB, pdf)
Table S1
mmc2.pdf (120KB, pdf)

References

  • 1.Wordinger R.J., Clark A.F. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629–667. doi: 10.1016/s1350-9462(98)00035-4. [DOI] [PubMed] [Google Scholar]
  • 2.Mehta S. Age-related macular degeneration. Prim Care. 2015;42:377–391. doi: 10.1016/j.pop.2015.05.009. [DOI] [PubMed] [Google Scholar]
  • 3.Guymer R.H., Campbell T.G. Age-related macular degeneration. Lancet. 2023;401:1459–1472. doi: 10.1016/S0140-6736(22)02609-5. [DOI] [PubMed] [Google Scholar]
  • 4.Sarkar A., Dyawanapelly S. Nanodiagnostics and Nanotherapeutics for age-related macular degeneration. J Controlled Release. 2021;329:1262–1282. doi: 10.1016/j.jconrel.2020.10.054. [DOI] [PubMed] [Google Scholar]
  • 5.Sarkar A., Junnuthula V., Dyawanapelly S. Ocular therapeutics and molecular delivery strategies for neovascular age-related macular degeneration (nAMD) Int J Mol Sci. 2021;22:10594. doi: 10.3390/ijms221910594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Girgis S., Lee L.R. Treatment of dry age-related macular degeneration: a review. Clin Exp Ophthalmol. 2023;51:835–852. doi: 10.1111/ceo.14294. [DOI] [PubMed] [Google Scholar]
  • 7.Kong X., Wang K., Sun X., Witt R.E. Comparative study of the retinal vessel anatomy of rhesus monkeys and humans. Clin Exp Ophthalmol. 2010;38:629–634. doi: 10.1111/j.1442-9071.2010.02290.x. [DOI] [PubMed] [Google Scholar]
  • 8.Lin K.H., Tran T., Kim S., et al. Advanced retinal imaging and ocular parameters of the Rhesus Macaque eye. Translational Vis Sci Technology. 2021;10:7. doi: 10.1167/tvst.10.6.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jasinska A.J. Resources for functional genomic studies of health and development in nonhuman primates. Am J Phys Anthropol. 2020;171(S70):174–194. doi: 10.1002/ajpa.24051. [DOI] [PubMed] [Google Scholar]
  • 10.Wu J., Liu W., Zhu S., et al. Design, methodology, and preliminary results of the non-human primates eye study. BMC Ophthalmol. 2023;23:53. doi: 10.1186/s12886-023-02796-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kanadani F.N., Hood D.C., Grippo T.M., et al. Structural and functional assessment of the macular region in patients with glaucoma. Br J Ophthalmol. 2006;90:1393–1397. doi: 10.1136/bjo.2006.099069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Haghpanah S., Zekavat O.R., Safaei S., et al. Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia. BMC Ophthalmol. 2022;22:279. doi: 10.1186/s12886-022-02490-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tangelder G.J.M., Van der Heijde R.G.L., Polak B.C.P., Ringens P.J. Precision and reliability of retinal thickness measurements in foveal and extrafoveal areas of healthy and diabetic eyes. Invest Opthalmol Vis Sci. 2008;49:2627–2634. doi: 10.1167/iovs.07-0820. [DOI] [PubMed] [Google Scholar]
  • 14.Zaharova E., Sherman J. The use of SD-OCT in the differential diagnosis of dots, spots and other white retinal lesions. Eye Brain. 2011;3:69–80. doi: 10.2147/EB.S23208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Virgili G., Menchini F., Dimastrogiovanni A.F., et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Opthalmology Vis Sci. 2007;48:4963–4973. doi: 10.1167/iovs.06-1472. [DOI] [PubMed] [Google Scholar]
  • 16.Kousha O., Delle Fave M.M., Cozzi M., et al. Diabetic maculopathy: multicolour and SD-OCT versus fundus photography. BMJ Open Ophthalmol. 2021;6:e000514. doi: 10.1136/bmjophth-2020-000514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Virgili G., Menchini F., Casazza G., et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1 doi: 10.1002/14651858.CD008081.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ruia S., Saxena S., Gemmy Cheung C.M., et al. Spectral Domain optical coherence tomography features and classification systems for diabetic macular Edema. Asia Pac J Ophthalmol. 2016;5:360–367. doi: 10.1097/APO.0000000000000218. [DOI] [PubMed] [Google Scholar]
  • 19.El-Dairi M. Optical coherence tomography in the management of congenital glaucoma. Br J Ophthalmol. 2014;98:149–150. doi: 10.1136/bjophthalmol-2013-303723. [DOI] [PubMed] [Google Scholar]
  • 20.Mwanza J.-C., Budenz D.L. Optical coherence tomography platforms and parameters for glaucoma diagnosis and progression. Curr Opin Ophthalmol. 2016;27:102–110. doi: 10.1097/ICU.0000000000000231. [DOI] [PubMed] [Google Scholar]
  • 21.Yiu G., Chung S.H., Mollhoff I.N., et al. Long-term evolution and remodeling of soft Drusen in rhesus macaques. Invest Ophthalmol Vis Sci. 2020;61:32. doi: 10.1167/iovs.61.2.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wang Y., Fang Q., Zhang C., et al. Multimodal imaging and electroretinography highlights the role of VEGF in the laser-induced subretinal fibrosis of monkey. Exp Eye Res. 2021;203 doi: 10.1016/j.exer.2020.108417. [DOI] [PubMed] [Google Scholar]
  • 23.Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86:238–242. doi: 10.1136/bjo.86.2.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Xue Y., Cao Y., Fan S., et al. Nonhuman primate eyes display variable growth and aging rates in alignment with human eyes. Invest Ophthalmol Vis Sci. 2023;64:23. doi: 10.1167/iovs.64.11.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Denk N., Maloca P., Steiner G., et al. Macular thickness measurements of healthy, naïve cynomolgus monkeys assessed with Spectral-Domain Optical Coherence Tomography (SD-OCT) Plos One. 2019;14 doi: 10.1371/journal.pone.0222850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Acott T.S., Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543–561. doi: 10.1016/j.exer.2008.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Vranka J.A., Kelley M.J., Acott T.S., Keller K.E. Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma. Exp Eye Res. 2015;133:112–125. doi: 10.1016/j.exer.2014.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ziylan S., Kiziloglu O.Y., Yenerel N.M., et al. Macular Thickness in highly Myopic children aged 3 to 7 years. J Pediatr Ophthalmol Strabismus. 2015;52:282–286. doi: 10.3928/01913913-20150526-01. [DOI] [PubMed] [Google Scholar]
  • 29.Kanthaswamy S., Ng J., Satkoski Trask J., et al. The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research. J Med Primatol. 2013;42:120–131. doi: 10.1111/jmp.12043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.O'Connor S.L., Blasky A.J., Pendley C.J., et al. Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques. Immunogenetics. 2007;59:449–462. doi: 10.1007/s00251-007-0209-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kelty P.J., Payne J.F., Trivedi R.H., et al. Macular thickness assessment in healthy eyes based on ethnicity using stratus OCT optical coherence tomography. Invest Opthalmol Vis Sci. 2008;49:2668–2672. doi: 10.1167/iovs.07-1000. [DOI] [PubMed] [Google Scholar]
  • 32.Tariq Y.M., Li H.T., Burlutsky G., Mitchell P. Ethnic differences in macular thickness. Clin Exp Ophthalmol. 2011;39:893–898. doi: 10.1111/j.1442-9071.2011.02593.x. [DOI] [PubMed] [Google Scholar]
  • 33.Chu E.R., Gonzalez J.M., Jr., Tan J.C. Tissue-based imaging model of human trabecular meshwork. J Ocul Pharmacol Ther. 2014;30:191–201. doi: 10.1089/jop.2013.0190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.von Hanno T., Lade A.C., Mathiesen E.B., et al. Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: the Tromsø Eye Study (2007–2008) Acta Ophthalmol. 2016;95:262–269. doi: 10.1111/aos.13337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Patel P.J., Foster P.J., Grossi C.M., et al. Spectral-Domain optical coherence tomography imaging in 67 321 adults. Ophthalmology. 2016;123:829–840. doi: 10.1016/j.ophtha.2015.11.009. [DOI] [PubMed] [Google Scholar]
  • 36.Gupta P., Sidhartha E., Tham Y.C., et al. Determinants of macular thickness using spectral domain optical coherence tomography in healthy eyes: the Singapore Chinese eye Study. Invest Opthalmol Vis Sci. 2013;54:7968–7972. doi: 10.1167/iovs.13-12436. [DOI] [PubMed] [Google Scholar]
  • 37.Liton P.B., Gonzalez P., Epstein D.L. The role of proteolytic cellular systems in trabecular meshwork homeostasis. Exp Eye Res. 2009;88:724–728. doi: 10.1016/j.exer.2008.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Huynh S.C., Wang X.Y., Rochtchina E., Mitchell P. Distribution of macular thickness by optical coherence tomography: findings from a population-based Study of 6-YEAR-Old children. Invest Opthalmol Vis Sci. 2006;47:2351–2357. doi: 10.1167/iovs.05-1396. [DOI] [PubMed] [Google Scholar]
  • 39.Borras T., Comes N. Evidence for a calcification process in the trabecular meshwork. Exp Eye Res. 2009;88:738–746. doi: 10.1016/j.exer.2008.11.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Li T., Adhi M., Aziz S., et al. Macular thickness by Age and gender in healthy eyes using spectral domain optical coherence tomography. PLoS One. 2012;7:e37638. doi: 10.1371/journal.pone.0037638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Choovuthayakorn J., Watanachai N., Chaikitmongkol V., et al. Macular thickness measured by spectral-domain optical coherence tomography in healthy Thai eyes. Jpn J Ophthalmol. 2012;56:569–576. doi: 10.1007/s10384-012-0192-x. [DOI] [PubMed] [Google Scholar]
  • 42.Duan X.R., Liang Y.B., Friedman D.S., et al. Normal macular thickness measurements using optical coherence tomography in healthy eyes of adult Chinese persons: the Handan Eye Study. Ophthalmology. 2010;117:1585–1594. doi: 10.1016/j.ophtha.2009.12.036. [DOI] [PubMed] [Google Scholar]
  • 43.Myers C.E., Klein B.E.K., Meuer S.M., et al. Retinal thickness measured by spectral-domain optical coherence tomography in eyes without retinal abnormalities: the beaver dam eye Study. Am J Ophthalmol. 2015;159:445–456.e1. doi: 10.1016/j.ajo.2014.11.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Natung T., Keditsu A., Lyngdoh L.A., et al. Normal macular thickness in healthy Indian eyes using spectral domain optical coherence tomography. Asia Pac J Ophthalmol (Phila) 2016;5:176–179. doi: 10.1097/APO.0000000000000153. [DOI] [PubMed] [Google Scholar]
  • 45.Al-Zamil W.M., Al-Zwaidi F.M., Yassin S.A. Macular thickness in healthy Saudi adults. Saudi Med J. 2017;38:63–69. doi: 10.15537/smj.2017.1.17565. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1
mmc1.pdf (1.2MB, pdf)
Table S1
mmc2.pdf (120KB, pdf)

Articles from Ophthalmology Science are provided here courtesy of Elsevier

RESOURCES